Hagan, Thomas https://orcid.org/0000-0002-5254-5251
Gerritsen, Bram https://orcid.org/0000-0001-7065-3160
Tomalin, Lewis E. https://orcid.org/0000-0003-4545-7138
Fourati, Slim https://orcid.org/0000-0001-6609-7587
Mulè, Matthew P.
Chawla, Daniel G. https://orcid.org/0000-0001-7667-9337
Rychkov, Dmitri
Henrich, Evan
Miller, Helen E. R.
Diray-Arce, Joann
Dunn, Patrick https://orcid.org/0000-0003-1868-9689
Lee, Audrey
,
Deckhut-Augustine, A.
Gottardo, R.
Haddad, E. K.
Hafler, D. A.
Harris, E.
Farber, D.
Kleinstein, S. H.
Levy, O.
McElrath, J.
Montgomery, R. R.
Peters, B.
Pulendran, B.
Rahman, A.
Reed, E. F.
Rouphael, N.
Sarwal, M. M.
Sékaly, R. P.
Fernandez-Sesma, A.
Sette, A.
Stuart, K.
Togias, A.
Tsang, J. S.
Levy, Ofer https://orcid.org/0000-0002-5859-1945
Gottardo, Raphael https://orcid.org/0000-0002-3867-0232
Sarwal, Minne M.
Tsang, John S.
Suárez-Fariñas, Mayte
Sékaly, Rafick-Pierre
Kleinstein, Steven H. https://orcid.org/0000-0003-4957-1544
Pulendran, Bali https://orcid.org/0000-0001-6517-4333
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19 AI167903, U01 AI165527, U19-AI089992)
Article History
Received: 19 April 2022
Accepted: 12 September 2022
First Online: 31 October 2022
Competing interests
: O.L. is a named inventor on patents held by Boston Children’s Hospital regarding human in vitro systems modeling vaccine action and vaccine adjuvants. B.P. serves on the External Immunology Network of GSK, and on the scientific advisory board of Medicago, CircBio, Sanofi, EdJen and Boehringer-Ingelheim. S.H.K. receives consulting fees from Northrop Grumman and Peraton. T.H. owns stock in GSK and Pfizer. The remaining authors declare no competing interests.